Difficulty: Medium
Average Score: 66%
Practice
A Cytoprotective agent given with antisecretory agents to chelate proteins in ulcer base
Correct answer
B
Rationale
The correct answer is B) Colloidal bismuth.
Colloidal bismuth is a cytoprotective agent that forms a protective layer over the ulcer base by chelating proteins, which helps in healing and preventing further damage. When given with antisecretory agents, it provides a comprehensive approach to treating peptic ulcers.
A) Sucralfate works by forming a physical barrier at the ulcer site but does not chelate proteins like colloidal bismuth.
C) Misoprostol is a prostaglandin analog that helps reduce gastric acid secretion and increase mucosal protection, but it does not chelate proteins like colloidal bismuth.
D) Option D is incorrect as sucralfate and colloidal bismuth have distinct mechanisms of action.
In an educational context, understanding the mechanisms of action of different drugs used in treating peptic ulcers is crucial for healthcare professionals to make informed decisions based on the specific needs of the patient. Knowing how cytoprotective agents like colloidal bismuth interact with other medications can optimize treatment outcomes and minimize adverse effects.
Colloidal bismuth is a cytoprotective agent that forms a protective layer over the ulcer base by chelating proteins, which helps in healing and preventing further damage. When given with antisecretory agents, it provides a comprehensive approach to treating peptic ulcers.
A) Sucralfate works by forming a physical barrier at the ulcer site but does not chelate proteins like colloidal bismuth.
C) Misoprostol is a prostaglandin analog that helps reduce gastric acid secretion and increase mucosal protection, but it does not chelate proteins like colloidal bismuth.
D) Option D is incorrect as sucralfate and colloidal bismuth have distinct mechanisms of action.
In an educational context, understanding the mechanisms of action of different drugs used in treating peptic ulcers is crucial for healthcare professionals to make informed decisions based on the specific needs of the patient. Knowing how cytoprotective agents like colloidal bismuth interact with other medications can optimize treatment outcomes and minimize adverse effects.